we hereby submit the outcome of the Meeting of the Board of Director held on today i.e., Tuesday, October 14, 2025, at 06.00 p.m. and concluded on 07.40 p.m. inter alia considered and approved ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board of Saptak Chem And Business Ltd, which met on October 14, 2025, approved a preferential issue of 40 lakh convertible equity warrants at Rs. 10.50 per warrant, raising up to Rs. 4.20 crore from public-category investors. The warrants, each convertible into one equity share, require 25% upfront payment with the balance 75% due on exercise, and have an 18-month tenure. All 8 proposed allottees currently hold zero shares in the company, meaning their post-issue holding will collectively be about 78.85% on a fully diluted basis. The board also approved an EGM notice for November 12, 2025 (via video conferencing) to seek shareholder approval for the issue, and appointed Mr. Jubin Premji Gada as an Additional Non-Executive Independent Director.
This is a significant equity dilution event — existing shareholders could see their stake drop sharply because the 8 new allottees will hold nearly 79% on a fully diluted basis after conversion. However, the company is raising fresh capital (Rs. 4.20 crore) from new public investors, which is mildly positive for liquidity. Existing shareholders should track the EGM on November 12, 2025 closely, as their approval is required for the issue to go through.